Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2020-08-01
Reeks:Vaccines
Onderwerpen:
hepatocellular carcinoma
PD-L1
CTLA-4
oncolytic viruses
antigen peptide vaccines
DC vaccines
Online toegang:https://www.mdpi.com/2076-393X/8/3/447
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items